Fulminant viral hepatitis
MONDO:0018109Fulminant viral hepatitis is a rapid and severe impairment of liver functions (acute liver failure) with hepatic encephalopathy developing less than 8 weeks after the onset of jaundice, secondary to viral hepatitis mainly due to HBV, but also to HAV.
3 clinical trials for this condition and its sub-types, 3 tagged with Fulminant viral hepatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Could a common supplement help liver patients in intensive care?
Disease control Recruiting nowThis study looks at whether adding L-carnitine, a natural substance, to standard care can improve outcomes for critically ill adults with liver disease in the ICU. About 58 participants with conditions like liver failure or severe infections will be enrolled. Researchers will tra…
Phase 4 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
DNA clues could help predict liver failure in hepatitis b patients
Knowledge-focused Recruiting nowThis study looks at DNA methylation patterns in 100 people with severe liver failure caused by hepatitis B. Researchers aim to build a model that predicts how the disease will progress, which could help doctors make better treatment decisions. The study is observational and does …
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC